comparemela.com

Latest Breaking News On - John vandermosten - Page 9 : comparemela.com

Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2022 Results - Earnings Call Transcript

Protalix BioTherapeutics Inc. (NYSE:NYSE:PLX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Alexandra Schuman - LifeSci Advisors, IR Dror Bashan - President.

United-states
United-kingdom
Dror-bashan
John-vandermosten
Alexandra-schuman
David-warnock
Protalix-biotherapeutic
Eyal-rubin
Exchange-commission
Protalix-biotherapeutics-inc
Zacks-small-cap-research
Company-participants

GBS Inc.'s (GBS) CEO Dr. Steven Boyages on Q3 2022 Results - Earnings Call Transcript

vimarsana © 2020. All Rights Reserved.